KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Minority Interest: 2019-2020

Historic Minority Interest for Hims & Hers Health (HIMS) over the last 1 years, with Dec 2020 value amounting to $188.5 million.

  • Hims & Hers Health's Minority Interest fell 1.59% to $188.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $188.5 million, marking a year-over-year decrease of 1.59%. This contributed to the annual value of $188.5 million for FY2020, which is 1.59% down from last year.
  • Latest data reveals that Hims & Hers Health reported Minority Interest of $188.5 million as of Q4 2020, which was down 1.07% from $190.6 million recorded in Q3 2020.
  • Hims & Hers Health's Minority Interest's 5-year high stood at $192.9 million during Q1 2020, with a 5-year trough of $188.5 million in Q4 2020.
  • For the 2-year period, Hims & Hers Health's Minority Interest averaged around $191.2 million, with its median value being $191.2 million (2019).
  • Data for Hims & Hers Health's Minority Interest shows a maximum YoY declined of 1.59% (in 2020) over the last 5 years.
  • Quarterly analysis of 2 years shows Hims & Hers Health's Minority Interest stood at $191.6 million in 2019, then decreased by 1.59% to $188.5 million in 2020.
  • Its Minority Interest stands at $188.5 million for Q4 2020, versus $190.6 million for Q3 2020 and $192.8 million for Q2 2020.